NCT03491891 is a clinical trial in Stent Thrombosis, sponsored by The First Hospital of Jilin University.

Who is sponsoring NCT03491891?

NCT03491891 is sponsored by The First Hospital of Jilin University.

What condition does NCT03491891 study?

NCT03491891 studies Stent Thrombosis.

Is NCT03491891 still recruiting?

NCT03491891 is currently completed. Last updated 20 September 2019.

Are results published for NCT03491891?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-09-20 · How we verify

NCT03491891

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China

Completed Results posted Last updated 20 September 2019

What this trial tests

trial in Stent Thrombosis in 8,476 participants. Completed in 1 June 2019.

Timeline

1 January 2014

Primary endpoint
1 June 2015

1 June 2019

Quick facts

Lead sponsor	The First Hospital of Jilin University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	8,476
Start date	1 January 2014
Primary completion	1 June 2015
Estimated completion	1 June 2019
Sites	1 location across China

Conditions studied

Stent Thrombosis — all drugs for Stent Thrombosis →

Sponsor

The First Hospital of Jilin University

Who can join

18 and older, any sex, with Stent Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Very Late Stent Thrombosis Primary · Five years

very late stent thrombosis demonstrated by coronary angiography

Group	Value	95% CI
Derivation Cohort	92
Validation Cohort	35

Sponsor's own description

The investigators sought to identify and verify the potential correlates and mechanisms of Very Late Stent Thrombosis (VLST) after the implantation of new generation drug eluting steng in China from an analysis of multicenter registries.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Association Between S100A8/A9 and the Development of Very Late Stent Thrombosis in Patients With Acute Myocardial Infarction.
Wang X, Guan M, Zhang X, Ma T, et al · · 2020 · cited 10× · PMID 32734774 · DOI 10.1177/1076029620943295
A scoring system to predict the occurrence of very late stent thrombosis following percutaneous coronary intervention for acute coronary syndrome.
Wang X, Chen X, Tian T, You H, et al · · 2020 · cited 5× · PMID 32286484 · DOI 10.1038/s41598-020-63455-0

Verify or expand the search:

Other recruiting trials for Stent Thrombosis

Currently open trials in the same condition.

NCT07182799 — Starring Optical Coherence Tomography During Percutaneous Coronary Intervention Guidance · active not recruiting
NCT06880978 — Mini-Crush Or Controlled Balloon-Crush For True Coronary Bifurcation Lesions · recruiting
NCT06308952 — Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation · Phase 4 · recruiting
NCT06700018 — Flow Patterns and Stent Thrombosis · recruiting
NCT04436978 — What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? · Phase 4 · recruiting

Other The First Hospital of Jilin University trials

Trials by the same sponsor.

NCT07308340 — Rapid Identification of Infectious Pathogens in Severe Pneumonia Guided by Bronchoscopic Imaging and Lung CT · not yet recruiting
NCT07369531 — The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-pres · NA · recruiting
NCT07414160 — Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients · not yet recruiting
NCT07440368 — Enterocyte Injury and Acute Gastrointestinal Dysfunction in Critical Illness · not yet recruiting
NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03491891 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The First Hospital of Jilin University
Last refreshed: 20 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03491891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing